Last reviewed · How we verify
NCT06136923
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
NA trial testing CT-100-D-004-A in Multiple Sclerosis in 194 participants. Completed in 6 May 2024.
18 April 2024
Quick facts
| Lead sponsor | Click Therapeutics, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 194 |
| Start date | 19 October 2023 |
| Primary completion | 18 April 2024 |
| Estimated completion | 6 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CT-100-D-004-A
- CT-100-D-004-B
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
- Lung Cancer — all drugs for Lung Cancer →
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Click Therapeutics, Inc.
Who can join
Adults 22 to 65, any sex, with Multiple Sclerosis or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics. One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo) components. DiNaMo components target key neural systems (including but not limited to systems related to sensory-, perceptual-, affective-, pain-, attention-, cognitive control, social- and self-processing) to optimally improve a participant's health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06136923
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Click Therapeutics, Inc. trials
Trials by the same sponsor.
- NCT06486948 — An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-1 · NA · completed
- NCT06275659 — An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis · NA · completed
- NCT06136936 — A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia · NA · completed
- NCT06067984 — An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Sc · Phase 3 · completed
- NCT06004388 — Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06136923 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Click Therapeutics, Inc.
- Last refreshed: 13 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06136923.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing